'It's depressing'
Eli Lilly has finalized its acquisition of AtaiBeckley, a clinical-stage biopharmaceutical firm. The move integrates rapid-acting neuroplastogens into Lilly's neuroscience pipeline to target mental health conditions. Separately, a CDC report indicates 71% of U.S. adults experience fatigue, with younger adults and women most affected. In other regions, a tropical depression is located 230km from Da Nang amid heavy rain in central Vietnam, and Ladakh officials launched a project to revive the shrinking Tso Kar Lake using glacier water.
What changed
Eli Lilly completed its AtaiBeckley acquisition and new data from the CDC identifies fatigue levels among U.S. adults.
Live updates
-
Eli Lilly expands neuroscience pipeline via AtaiBeckley acquisition
Eli Lilly has finalized its acquisition of AtaiBeckley, a clinical-stage biopharmaceutical firm. The move integrates rapid-acting neuroplastogens into Lilly's neuroscience pipeline to target mental health conditions. Separately, a CDC report indicates 71% of U.S. adults experience fatigue, with younger adults and women most affected. In other regions, a tropical depression is located 230km from Da Nang amid heavy rain in central Vietnam, and Ladakh officials launched a project to revive the shrinking Tso Kar Lake using glacier water.
Why it matters
The pharmaceutical industry is increasing investment in rapid-acting therapies to address treatment-resistant mental health needs. This trend coincides with broader public health data on fatigue and national awareness efforts for suicide prevention. Environmental pressures in Asia and India are prompting large-scale infrastructure responses to weather and water scarcity.
What is confirmed
- Eli Lilly completed its acquisition of AtaiBeckley to expand its mental health pipeline.
- Ladakh Lieutenant Governor Vinai Kumar Saxena launched a project to revive Tso Kar Lake by channelising 320 million litres of glacier water daily.
- Tso Kar Lake has lost nearly 70 per cent of its water.
Still unconfirmed
- September is National Suicide Prevention Month.
What to watch next
- Clinical trial results for AtaiBeckley's neuroplastogens
- Progress reports on the Tso Kar Lake water channelisation project
confidence 90%Sources used for this update (7)
- vietnamnet.vn — Tropical depression 230km from Da Nang as heavy rain pounds central Vietnam
- www.psychologytoday.com — Two Ways to Unwittingly Make Your Loved One Feel Worse
- pulse2.com — Lilly Completes Acquisition Of AtaiBeckley To Expand Mental Health Pipeline
- www.nbcnews.com — Why are Americans so tired? CDC report highlights who’s feeling it most
- www.nola.com — Suicide Prevention Month highlights the importance of recognizing signs and reaching out for support
- telanganatoday.com — Ladakh launches project to revive shrinking Tso Kar Lake with glacier water
- theprint.in — Mega project launched to revive Ladakh’s Tso Kar lake with glacier water
-
Eli Lilly Acquires AtaiBeckley to Advance Depression Therapies
Eli Lilly and Company completed its acquisition of AtaiBeckley Inc. on September 11, 2026, to advance therapies aimed at treatment-resistant depression and other mental health conditions. This corporate transaction in the pharmaceutical sector addresses growing clinical needs in mental healthcare. Meanwhile, related developments in mental health and medical treatments span various international reports, including initiatives by NRX Pharmaceuticals and its HOPE Therapeutics division, alongside reports concerning mental well-being challenges in Cuba.
Why it matters
The pharmaceutical industry continues to consolidate around mental health therapeutics as demand rises for treatment-resistant depression solutions. Corporate investments in specialized biotech firms signal ongoing commercial efforts to expand psychiatric drug portfolios. These developments intersect with broader public health concerns regarding psychological well-being globally.
What is confirmed
- Eli Lilly and Company announced the successful completion of its acquisition of AtaiBeckley Inc. on September 11, 2026.
- The acquisition is intended to advance therapies for treatment-resistant depression and other mental health conditions.
Still unconfirmed
- NRX Pharmaceuticals' HOPE Therapeutics plans to deploy Zeta's TMS Robotic System.
- A KGB spy boss defected to seek Western medicine for impotence.
- Cuba is experiencing a severe mental health crisis impacting its population's well-being.
What to watch next
- Clinical trial updates for AtaiBeckley therapies under Eli Lilly
- Further commercial deployments by HOPE Therapeutics
confidence 100%Sources used for this update (6)
- www.finanznachrichten.de — Eli Lilly and Company: Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
- finance.yahoo.com — NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System
- www.mentalfloss.com — The Real-Life Herbs in 'Practical Magic' and What They’re Traditionally Used For
- www.dailymail.com — The handsome 6ft 4in KGB spy boss who defected - because he thought Western medicine could cure the impotence wrecking his marriage
- www.cubaheadlines.com — Cuba's Mental Health Crisis: A Nation on the Brink
- www.netimes.com.au — A Hillgrove miracle: is this the happiest workplace in the region?
-
England Close on Series Sweep Against Pakistan
England stands on the verge of a series sweep against Pakistan in the third men's cricket test, driven by standout performances from Brook, Smith, Lawrence, and Robinson. Pakistan's batting struggles during the match prompted player Shakeel to label the situation depressing as the hosts closed in on a whitewash on day two. Meanwhile, analyst Nasser Hussain pointed out Joe Root's struggles and an ongoing century drought for England against Pakistan as the sole concerns coming out of their improved post-Bazball batting lineup.
Why it matters
The third test match highlights Pakistan's persistent offensive difficulties while showcasing England's dominant form under bowler Robinson and key batters. A series sweep would cap off a challenging tour for the visiting side. Observers continue to monitor individual slumps like Root's despite overall improvements in the team's batting strategy.
What is confirmed
- Brook, Smith, Lawrence, and Robinson pushed England toward a third test win against Pakistan.
- Shakeel lamented Pakistan's batting woes by describing the situation as depressing.
- Nasser Hussain noted Joe Root's struggles and an England century drought against Pakistan as ongoing concerns.
What to watch next
- Conclusion of the third test match between England and Pakistan
- Official confirmation of a series sweep or whitewash by England
confidence 100%Sources used for this update (12)
- Cricinfo — 'It's depressing' - Shakeel laments Pakistan's batting woes
- BBC — England vs Pakistan: Brook, Smith, Lawrence and Robinson push hosts towards third Test win
- Al Jazeera — England close in on Pakistan whitewash in third Test as Robinson shines
- The Guardian — England close on series sweep against Pakistan: third men’s cricket Test, day two – as it happened
- skysports.com — Joe Root's struggles and England century drought against Pakistan the only concerns from improved post-Bazball batting, says Nasser Hussain
- www.vox.com — How — and why — to tell your doctor you’re feeling depressed
- www.jpost.com — Inside the UN: The gifts aren't gifts, they're influence - opinion
- www.aol.com — Assisted dying will not become law after MPs vote down bill in dramatic U-turn
- www.fool.com — Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- multiplesclerosisnewstoday.com — Pain, sleep, stress linked to fatigue severity in relapsing-remitting MS
- townhall.com — Another Massachusetts Mom Killed Her Kids and Here's What She's Asking of the Courts
- www.usatoday.com — The Healthier Choice Recovery Provides Outpatient Addiction Treatment Across Los Angeles